Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum LED Medical Diagnostics Inc LEDIF

"LED Medical Diagnostics Inc is a Canada based company engaged in development and marketing of a medical device under the trade name VELscope which is used in the dental industry to help identify oral soft tissue abnormalities including those which may be cancerous or precancerous. In addition, the company also features a Digital division that provides dentists and oral health diagnostic... see more

GREY:LEDIF - Post Discussion

LED Medical Diagnostics Inc > Q1 Financials Posted: Risk and Reward
View:
Post by ChaseYourDream on May 27, 2016 11:32am

Q1 Financials Posted: Risk and Reward

Numbers are a little worse than hoped, but with justifiable reasons provided. SP has dropped to .105 at open, and is likely to oscillate in this range for a while. If the market has already factored in this news, we may already be at or near the floor in SP.

The FS itself is only 4 pages, but read the MD&A before placing your sell order in a panic. The MD&A provides considerably more detail with clarity. My yellow flags have been raised, but there are a few positives as well:

Through most of 2014-2015 the SP was .30-.55, and the financial numbers were much as they are now: relatively modest losses; a rising deficit not yet too great to survive; What has changed is that then there was hope profitability might come sooner; now we know better. But compared with other Microcaps now trading at .10-20 LMD's current numbers and trends are above average; In other words, undervalued! The company has managed to maintain a decent Cash-on-Hand balance without any new financing this quarter; The costs of current product development are behind us, and the commitment to higher marketing expenses is a necessary investment in higher revenues, which are likely to increase from here while net expenses will not, so net gain/loss will improve.

ROI, the Bottom Line: Revenues should increase from present levels, but will they increase enough to get into the black? Typically Q4 is the peak of the revenue cycle. Q1 had some adverse conditions resulting in the current -.02 EPS instead of the projected -.01. Q2 and Q3 should look a little better by default; if revenue growth is kicking in as implied, they may even surprise us, but we need to know if they can continue to grow beyond the current cycle. Our long-term read on the potential for profitability will come with the Q4 numbers at the earliest.

My call: Downgraded overall, but as a LONG I am now a HOLD. In the SP range likely to prevail for the next months, this company will continue to offer excellent value for those willing to take on higher risk in return for a relatively large potential reward. As the year progresses there will be spikes in SP on encouraging news. Revenue growth will increase, but the real breakout will begin only when we have a FS showing break-even or a positive Net Gain. I consider the analyst target SP of $1.25 now very unlikely in 2016 (and may be downgraded soon) but a significant gain on current SP is not only possible but very probable into early 2017. If the net is positive for two consecutive quarters, SP appreciation is likely to become exponential. A 10x return on shares bought today (below .13) is within reason in 2017.

I am not a financial professional. Please do your own DD. This is all IMHO. In a year we will see if my crystal ball works as well as Umpatan's!
Comment by Umpatan on May 30, 2016 12:03am
We still have another leg down from here or two.  
Comment by Umpatan on May 30, 2016 12:11am
Dr. Gane and Lamar Rorberts is not making much more than your average local dental hygenist or even a bit less in terms of their salary in the $50K range.  Remember, I do not expect their ability to excercise their .18 cent/share OUT OF THE MONEY stock option.  It matters not how many warrants they provide at .18 cents if they are all going to expire worthless.  When the share price ...more  
Comment by bullmetal on May 30, 2016 8:33am
THUMPA - PERHAPS THE PLACE FOR YOU IS UTAH.
Comment by Umpatan on May 30, 2016 10:55am
Did you also graduate from Brigham Young University?
Comment by DanDGanz on May 30, 2016 12:23pm
try 200K salary range 
Comment by DanDGanz on May 30, 2016 12:28pm
Lamar Roberts President, Director and President of LED Dental Ltd,LED Medical Diagnostics, Inc.   Age Total Calculated Compensation This person is connected to 4 board members in 1 different organizations across 1 different industries. See Board Relationships -- $235,398 ...more  
Comment by DanDGanz on May 30, 2016 12:30pm
David Gane DDS Chief Executive Officer and Director,LED Medical Diagnostics, Inc.   Age Total Calculated Compensation This person is connected to 4 board members in 1 different organizations across 2 different industries. See Board Relationships -- $235,802 As of Fiscal ...more  
Comment by Umpatan on May 30, 2016 4:59pm
Stock options included. Lmd was above .18 at that time and it had value then. This is no longer the case. 18 cents cannot be met before their warrants expire out of money.
Comment by Umpatan on May 30, 2016 5:13pm
This means that Bristol is working for $7000 only and the .18 cents stock option is worthless out of the money acquisition that adds no value. This also means the company managed to sell this empty dream in exchange for a service. To this this is a smart move for the company.
Comment by ChaseYourDream on Jun 13, 2016 11:30am
2 weeks past Q1 FS. How R we doing? 12-month target now $1 even. SP softer @ .10-.13 averaging .115 Other recent predictions (same person saying SELL and BUY!): .13, .11, .09, .05, .03... gotta be right some of the time. My read of LT strength to show by Q4 or Q1 2017 (no comments?) Q2 and Q3 should be a titch better (No comments?) Doldrums likely to persist until news changes perspective ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse